EverSource Wealth Advisors’s Xometry XMTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$77K Sell
798
-117
-13% -$8.36K ﹤0.01% 1523
2026
Q1
$37.4K Buy
915
+2
+0.2% +$106 ﹤0.01% 2097
2025
Q4
$54.3K Buy
913
+47
+5% +$2.65K ﹤0.01% 1691
2025
Q3
$47.2K Sell
866
-9
-1% -$391 ﹤0.01% 1758
2025
Q2
$29.6K Sell
875
-25
-3% -$733 ﹤0.01% 1987
2025
Q1
$22.4K Buy
900
+20
+2% +$628 ﹤0.01% 1632
2024
Q4
$37.5K Sell
880
-291
-25% -$8.23K ﹤0.01% 1318
2024
Q3
$21.5K Sell
1,171
-2
-0.2% -$33 ﹤0.01% 1452
2024
Q2
$17.2K Sell
1,173
-131
-10% -$2.06K ﹤0.01% 1577
2024
Q1
$23.3K Buy
1,304
+924
+243% +$25K ﹤0.01% 1287
2023
Q4
$13.6K Buy
380
+274
+258% +$5.88K ﹤0.01% 1420
2023
Q3
$1.8K Sell
106
-37
-26% -$700 ﹤0.01% 2040
2023
Q2
$3.03K Buy
143
+59
+70% +$1.03K ﹤0.01% 1920
2023
Q1
$1.26K Buy
84
+54
+180% +$1.42K ﹤0.01% 2060
2022
Q4
$967 Sell
30
-24
-44% -$1.12K ﹤0.01% 2097
2022
Q3
$3K Buy
+54
New +$2.52K ﹤0.01% 1602
2022
Q1
Sell
-162
Closed -$8K 1870
2021
Q4
$8K Buy
+162
New +$8.33K ﹤0.01% 1074

Other funds holding XMTR

EverSource Wealth Advisors's XMTR Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Xometry (XMTR) stake by 13% in Q2 2026, selling an estimated $8.36K and leaving 798 shares worth $77K. The position accounts for ﹤0.01% of the portfolio, ranked #1523.

EverSource Wealth Advisors first reported a position in XMTR in Q4 2021 and has held it in 17 quarters since. 293 funds tracked by Wall St. Rank hold XMTR as of Q2 2026.

  • EverSource Wealth Advisors held 798 shares of Xometry worth $77K as of Q2 2026.
  • EverSource Wealth Advisors sold 117 Xometry shares in Q2 2026, an estimated $8.36K.
  • Xometry made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #1523 holding.
  • EverSource Wealth Advisors first reported a position in Xometry in Q4 2021 and has held it in 17 quarters since.
  • 293 funds tracked by Wall St. Rank held Xometry as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.